Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research
November 13, 2025
November 13, 2025
PRINCETON, New Jersey, Nov. 13 -- Bristol Myers Squibb, a biopharmaceutical company, issued the following news release:
* * *
Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research
Collaboration Leverages Data-Driven Approach to Bring Cutting-Edge Clinical Trials to More Communities
*
Nashville, Tenn. (Nov. 12, 2025) - . . .
* * *
Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research
Collaboration Leverages Data-Driven Approach to Bring Cutting-Edge Clinical Trials to More Communities
*
Nashville, Tenn. (Nov. 12, 2025) - . . .
